Send to

Choose Destination
ACS Med Chem Lett. 2014 Mar 4;5(4):286-7. doi: 10.1021/ml500084u. eCollection 2014 Apr 10.

Inhibitors of Factor XIa and Plasma Kallikrein May Treat Thromboembolic Disorders and Many Diabetes Complications.

Author information

Therachem Research Medilab (India) Pvt. Ltd. , Jaipur, India.

Supplemental Content

Full text links

Icon for American Chemical Society Icon for PubMed Central
Loading ...
Support Center